Medicine - Hematology and Medical Oncology

Research output

Research output per year 1949 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 294905 Citations
• 233 h-index
• 4028 Article
• 684 Review article
• 251 Letter
• 202 Comment/debate
• 303 More
  • 131 Chapter
  • 100 Editorial
  • 41 Short survey
  • 12 Conference contribution
  • 6 Foreword/postscript
  • 5 Book
  • 5 Paper
  • 3 Conference article

Research output per year

Research output per year

Search results

• 2022

  Bigger isn't always better: the ESMO dose de-intensification guideline framework

  Shapiro, C. L., Jul 2022, In: Annals of Oncology. 33, 7, p. 672-673 2 p.

  Research output: Contribution to journal › Editorial

• Editorial for “Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-Treatment Patients with Bladder Cancer: A Prospective Single-Center Study”

  Lewis, S. & Galsky, M., Jan 2022, In: Journal of Magnetic Resonance Imaging. 55, 1, p. 287-288 2 p.

  Research output: Contribution to journal › Editorial

• Lung Cancer Disparities Outcomes: The Urgent Need for Narrowing Care Gaps

  Wisnivesky, J. P. & Smith, C. B., 1 Apr 2022, In: Journal of Clinical Oncology. 71, JCO.22.00321.

  Research output: Contribution to journal › Editorial

  Open Access

• The Effect of Fedratinib, A Selective Inhibitor of Janus Kinase 2, on Weight and Metabolic Parameters in Patients with Intermediate- or High-risk Myelofibrosis

  Tremblay, D., Cavalli, L., Sy, O., Rose, S. & Mascarenhas, J., Jul 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 7, p. e463-e466

  Research output: Contribution to journal › Editorial
  1 Scopus citations

• Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma

  Mouhieddine, T. H., Hieulle, J., Moshier, E., Richard, S., Richter, J., Cho, H. J., Parekh, S., Barlogie, B., Chari, A., Jagannath, S. & Madduri, D., Feb 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 2, p. 129-132 4 p.

  Research output: Contribution to journal › Editorial
• 2021

  (Distinct) origins of IgM myeloma

  Laganà, A. & Parekh, S., 18 Nov 2021, In: Blood. 138, 20, p. 1914-1915 2 p.

  Research output: Contribution to journal › Editorial

  Open Access

• Editorial introductions

  Lebbé, C., Dumaz, N., Hainaut, P. & Boffetta, P., 1 Mar 2021, In: Current Opinion in Oncology. 33, 2, p. V-VI

  Research output: Contribution to journal › Editorial

  Open Access

• Multiple Myeloma: "if You Don't Stop to Look around Once in a While. You Could Miss It"

  Richter, J. R., 2021, In: Cancer journal (Sudbury, Mass.). 27, 3, p. 183-184 2 p.

  Research output: Contribution to journal › Editorial

• Mutations in MPNs to “interfere-on”

  Mascarenhas, J., 2 Dec 2021, In: Blood. 138, 22, p. 2156-2157 2 p.

  Research output: Contribution to journal › Editorial

  Open Access

• Reprogramming and cancer

  Papapetrou, E. P. & Lee, D. F., Apr 2021, In: Stem Cell Research. 52, 102249.

  Research output: Contribution to journal › Editorial

  Open Access

• The Dangers of “Us Versus Them”: Epidemics Then and Now

  Barr, J., McKay, R. A. & Doroshow, D. B., Mar 2021, In: Journal of General Internal Medicine. 36, 3, p. 795-796 2 p.

  Research output: Contribution to journal › Editorial

  Open Access

• The New Science and Concepts That Underlie Current and Future Treatments for Myeloproliferative Neoplasms

  Hoffman, R., Levine, R., Mascarenhas, J. & Rampal, R. K., Apr 2021, In: Hematology/Oncology Clinics of North America. 35, 2, p. xvii-xix

  Research output: Contribution to journal › Editorial
• 2020

  Abbreviated MRI for HCC surveillance: is it ready for clinical use?

  Vietti Violi, N. & Taouli, B., 1 Aug 2020, In: European Radiology. 30, 8, p. 4147-4149 3 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Multicenter Studies 100%
  • Prospective Studies 73%
  • Injections 66%
  3 Scopus citations

• COVID-19 infection in cancer patients: early observations and unanswered questions

  Oh, W. K., Jul 2020, In: Annals of Oncology. 31, 7, p. 838-839 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  29 Scopus citations

• Imaging biomarkers of diffuse liver disease: current status

  Taouli, B. & Alves, F. C., 1 Nov 2020, In: Abdominal Radiology. 45, 11, p. 3381-3385 5 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Liver Diseases 100%
  • Biomarkers 77%
  • Molecular Imaging 46%
  • Radiology 39%
  • Direction compound 28%
  3 Scopus citations

• Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network

  Levine, J. E., Antin, J. H., Allen, C. E., Burroughs, L. M., Cooke, K. R., Devine, S., Heslop, H., Nakamura, R., Talano, J. A., Yanik, G. & DiFronzo, N., May 2020, In: Biology of Blood and Marrow Transplantation. 26, 5, p. e94-e100

  Research output: Contribution to journal › Editorial

  Open Access

  • Hematologic Diseases 100%
  • Bone Marrow 62%
  • Advisory Committees 60%
  • Clinical Trials 55%
  • Transplants 53%
  3 Scopus citations

• Understanding the mechanistic features of cancer metastasis

  Sosa, M. S. & Bravo-Cordero, J. J., 1 Feb 2020, In: Cancer Reports. 3, 1, e1238.

  Research output: Contribution to journal › Editorial
• 2019

  Atezolizumab in “Real World” Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?

  Patel, V. G. & Galsky, M. D., Jul 2019, In: European Urology. 76, 1, p. 82-83 2 p.

  Research output: Contribution to journal › Editorial

• Central nervous system metastases in triple-negative breast cancer: A step in the right direction

  Shreenivas, A. & Shapiro, C. L., 1 May 2019, In: Breast Journal. 25, 3, p. 361-362 2 p.

  Research output: Contribution to journal › Editorial

• Conditionally Reprogrammed Patient-derived Cells: A Step Forward Towards Personalized Medicine?

  Martini, A., Sfakianos, J. P. & Galsky, M. D., Oct 2019, In: European Urology. 76, 4, p. 435-436 2 p.

  Research output: Contribution to journal › Editorial
  4 Scopus citations

• DNA damage response as biomarkers informing a precision medicine approach to bladder cancer: what are the next steps?

  Niglio, S. & Galsky, M. D., 2 Jan 2019, In: Expert Review of Precision Medicine and Drug Development. 4, 1, p. 7-9 3 p.

  Research output: Contribution to journal › Editorial

• Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?

  Marcellino, B., Hoffman, R. & Mascarenhas, J., Jan 2019, In: Leukemia Research. 76, p. 94-95 2 p.

  Research output: Contribution to journal › Editorial
  1 Scopus citations

• Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis

  Rota, M., Pizzato, M., La Vecchia, C. & Boffetta, P., 1 Jul 2019, In: Annals of Oncology. 30, 7, p. 1040-1043 4 p., mdz145.

  Research output: Contribution to journal › Editorial

  Open Access
  15 Scopus citations

• New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches

  Bar-Natan, M. & Hoffman, R., 2019, In: Haematologica. 104, 1, p. 3-6 4 p.

  Research output: Contribution to journal › Editorial

  Open Access
  12 Scopus citations
• 2018

  Editorial reversing resistance to antiandrogens with a histone deacetylase inhibitor

  Ferrari, A. C., 1 Dec 2018, In: Oncotarget. 9, 99, p. 37284-37285 2 p.

  Research output: Contribution to journal › Editorial

• First-line treatment of hormone-sensitive metastatic prostate cancer: Is there a single standard of care?

  Tsao, C. K. & William, K. O., 10 Apr 2018, In: Journal of Clinical Oncology. 36, 11, p. 1060-1061 2 p.

  Research output: Contribution to journal › Editorial
  13 Scopus citations

• Impact of Heart Failure on Cancer Incidence: A Complicated Question ^∗

  Boffetta, P. & Malhotra, J., 10 Apr 2018, In: Journal of the American College of Cardiology. 71, 14, p. 1511-1512 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  8 Scopus citations

• Preface: Understanding and targeting minimal residual disease: A path to change cancer patient outcomes

  Aguirre-Ghiso, J. A., 2018, In: Advances in Experimental Medicine and Biology. 1100, p. v-vi

  Research output: Contribution to journal › Editorial

• 2017

  Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?

  Galsky, M. D., Sfakianos, J. P. & Ferket, B. S., 1 Oct 2017, In: European Urology. 72, 4, p. 555-556 2 p.

  Research output: Contribution to journal › Editorial
  3 Scopus citations

• Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example

  on behalf of the Board of the Metastasis Research Society, 1 Dec 2017, In: Clinical and Experimental Metastasis. 34, 8, p. 443-447 5 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Breast Neoplasms 100%
  • Research Personnel 27%
  • Therapeutics 25%
  • Neoplasm Metastasis 24%
  1 Scopus citations

• Progress towards molecular patient stratification of hepatocellular carcinoma: Lost in translation?

  Chiang, D. Y. & Villanueva, A., Nov 2017, In: Journal of Hepatology. 67, 5, p. 893-895 3 p.

  Research output: Contribution to journal › Editorial
  5 Scopus citations
• 2016

  Adverse event reporting in oncology clinical trials - lost in translation?

  Sivendran, S. & Galsky, M. D., 2 Jul 2016, In: Expert Opinion on Drug Safety. 15, 7, p. 893-896 4 p.

  Research output: Contribution to journal › Editorial

  Open Access
  12 Scopus citations

• Association of Increased Cancer Risk With Heart Failure

  Malhotra, J. & Boffetta, P., 19 Jul 2016, In: Journal of the American College of Cardiology. 68, 3, p. 272-273 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  5 Scopus citations

• Docetaxel for Metastatic Hormone-sensitive Prostate Cancer: Urgent Need to Minimize the Risk of Neutropenic Fever

  Tsao, C. K., Galsky, M. D. & Oh, W. K., 2016, In: European Urology. 70, 5, p. 707-708 2 p.

  Research output: Contribution to journal › Editorial

  • Docetaxel 100%
  • Castration 98%
  • Prostatic Neoplasms 70%
  • Fever 67%
  • Hormones 63%
  14 Scopus citations

• Environmental emissions, public health and lung cancer risk

  Swanton, C., Boffetta, P., Peston, R. & Soria, J. C., 1 Feb 2016, In: Annals of Oncology. 27, 2, p. 211-212 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  8 Scopus citations

• Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease

  Taouli, B. & Serfaty, L., 1 Mar 2016, In: Gastroenterology. 150, 3, p. 553-556 4 p.

  Research output: Contribution to journal › Editorial
  11 Scopus citations

• Reflections on nutritional cancer epidemiology

  Boffetta, P., 1 Jan 2016, In: American Journal of Clinical Nutrition. 103, 1, p. 3-4 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  1 Scopus citations

• Rethinking clinical trial design: Maximizing the results from each clinical trial participant

  Etra, A. & Shapiro, C. L., 2016, In: Translational Cancer Research. 5, p. S1044-S1046

  Research output: Contribution to journal › Editorial

• The application of mass spectrometry to leukemia drug discovery

  Roboz, G. J. & Roboz, J., 1 Nov 2016, In: Expert Opinion on Drug Discovery. 11, 11, p. 1029-1032 4 p.

  Research output: Contribution to journal › Editorial

  Open Access
  2 Scopus citations
• 2015

  Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen: Are we measuring disease burden or disease biology?

  Gartrell, B. A. & Galsky, M. D., 1 Feb 2015, In: European Urology. 67, 2, p. 231-232 2 p.

  Research output: Contribution to journal › Editorial
  2 Scopus citations

• Improving fitness to achieve health: Shifting the focus from theory to practice

  Baber, U. & Boffetta, P., 19 May 2015, In: Journal of the American College of Cardiology. 65, 19, p. 2101-2103 3 p.

  Research output: Contribution to journal › Editorial

  Open Access
  4 Scopus citations

• Role of prophylactic bilateral tonsillectomy as a cancer preventive strategy

  Misiukiewicz, K. & Posner, M., 1 Jul 2015, In: Cancer Prevention Research. 8, 7, p. 580-582 3 p.

  Research output: Contribution to journal › Editorial

  • Tonsillectomy 100%
  • Squamous Cell Carcinoma 33%
  • Vaccination 32%
  • Incidence 29%
  • Biomarkers 26%
  6 Scopus citations

• Screening for complex diseases and personalized health care

  Boccia, S., Boffetta, P. & Villari, P., 14 Jan 2015, In: BioMed Research International. 2015, 135931.

  Research output: Contribution to journal › Editorial

  Open Access

• The usual SASPects of liver cancer

  Lujambio, A. & Villanueva, A., 2015, In: Aging. 7, 6, p. 348-349 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  3 Scopus citations
• 2014

  A quick guide to cancer epidemiology

  Boffetta, P., Boccia, S. & La Vecchia, C., 2014, In: Epidemiology Biostatistics and Public Health. 11, 1

  Research output: Contribution to journal › Editorial
  6 Scopus citations

• Brachyury: A new player in promoting breast cancer aggressiveness

  Pires, M. M. & Aaronson, S. A., 14 May 2014, In: Journal of the National Cancer Institute. 106, 5

  Research output: Contribution to journal › Editorial
  10 Scopus citations

• Cancer in low- and medium-income countries

  Boffetta, P. & Islami, F., 1 Sep 2014, In: Annals of Global Health. 80, 5, p. 345 1 p.

  Research output: Contribution to journal › Editorial

  Open Access
  2 Scopus citations

• CARs move to the fast lane

  Davila, M. L. & Papapetrou, E. P., Mar 2014, In: Molecular Therapy. 22, 3, p. 477-478 2 p.

  Research output: Contribution to journal › Editorial

  Open Access
  3 Scopus citations

• El virus del tumor de mama humano (HMTV) en 2014

  Pogo, B. G. T., 1 Dec 2014, In: Medicina. 74, 5, p. 415-417 3 p.

  Research output: Contribution to journal › Editorial

• Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs

  Alabanza, L., Gnjatic, S., Bhardwaj, N. & Brody, J., 2014, In: OncoImmunology. 3, 1, e27580.

  Research output: Contribution to journal › Editorial

  Open Access
  2 Scopus citations